Research Progress of Inorganic Nanoparticles in Cancer Therapy
WU Xin1, ZENG lisheng2, WANG Jianlong1, LI Jian3
1 Department of Spinal Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China 2 Department of Orthopedics Department, Baojing People's Hospital of Hunan Province, Xiangxi 416500, China 3 Department of Blood Transfusion, Third Xiangya Hospital, Central South University, Changsha 410013, China
Abstract: Nanoparticles plays an important role in cancer therapy. In recent years, Nanoparticles have been studied in a number of areas, including drug delivery, vaccine development, antimicrobial, diagnostic, cancer treatment and imaging tools. Nanoparticles are divided into organic nanoparticles and inorganic nanoparticles. Inorganic nanoparticles are widely concerned because of their unique materials, size-dependent physical-chemical properties and special optical/electromagnetic properties, which are not possessed by organic nanoparticles. In cancer therapy, the choice of appropriate method of inorganic nanoparticles and collocation will bring better results for treatment.
邬欣, 曾利胜, 王剑龙, 李建. 无机纳米颗粒在癌症治疗中的研究进展[J]. 材料导报, 2021, 35(Z1): 87-93.
WU Xin, ZENG lisheng, WANG Jianlong, LI Jian. Research Progress of Inorganic Nanoparticles in Cancer Therapy. Materials Reports, 2021, 35(Z1): 87-93.
1 Molassiotis A, Cheng H L, Leung K T, et al.Brain and Behavior,2019,9(6),e01312. 2 Zhang J, Du Q, Song X, et al.Theranostics,2020,10(6),2621. 3 Bor G, Mat Azmi I D, Yaghmur A.Therapeutic Delivery,2019,10(2),113. 4 Ghilli M, Carretta E, Filippo F D, et al.European Journal of Cancer Care: the Official Journal of the European Oncology Nursing Society, 2017,26(4),51. 5 Bregoli L, Movia D, Gavigan-Imedio J D, et al.Nanomedicine : Nanotechnology, Biology, and Medicine,2016,12(1),81. 6 Lambert E, Gorantla V S, Janjic J M.Nanomedicine (London, England),2019,14(20),2697. 7 Xu M, Liu J, Xu X, et al.Materials (Basel, Switzerland),2018,11(10),81. 8 Li J, Huang X Y, Huang R, et al.CARBON,2019,132(146),660. 9 Heuer-Jungemann A, Feliu N, Bakaimi I, et al.Chemical Reviews,2019,119(8),4819. 10 Bayda S, Hadla M, Palazzolo S, et al.Current Medicinal Chemistry,2018,25(34),4269. 11 Bharti S, Kaur G, Jain S, et al.Journal of Drug Targeting,2019,27(8),813. 12 Vines J B, Yoon J H, Ryu N E, et al.Frontiers in Chemistry,2019,7(167),121. 13 Cherukula K, Manickavasagam Lekshmi K, Uthaman S, et al.Nanomaterials (Basel, Switzerland),2016,6(4),76. 14 Eom K, Byun K M, Jun S B, et al.Biophysical Journal,2018,115(8),1481. 15 Khunsuk P O, Chawalitpong S, Sawutdeechaikul P, et al.Molecular Pharmaceutics,2018,15(1),164. 16 Mayle K M, Dern K R, Wong V K, et al.SLAS Technology,2017,22(1),18. 17 Xu X, Chong Y, Liu X, et al.Acta Biomater,2019,56(84),328. 18 Loiseau A, Asila V, Boitel-Aullen G, et al.Biosensors,2019,9(2),78. 19 Verry C, Sancey L, Dufort S, et al.BMJ Open,2019,9(2),e023591. 20 US National Library of Medicine. ClinicalTrials.gov.[2019.01.28]https://clinicaltrials.gov/ct2/show/NCT03818386?term. 21 Verry C, Porcel E, Chargari C, et al.Cancer Radiother,2019,23(8),917. 22 Khalladi N and Thariat J.Bull Cancer,2019,106(12),1070. 23 Xie L, Jin W, Chen H, et al.J Biomed Nanotechnol,2019,15(2),215. 24 Carvalho S M, Leonel A G, Mansur A A P, et al.Biomater Sci,2019,7(5),2102. 25 Pang C, Brunelli A, Zhu C, et al.Nanotoxicology,2016,10(2),129. 26 Wilhelm S, Kaiser M, Wurth C, et al.Nanoscale,2015,7(4),1403. 27 Yang K, Wang C L, Ding S, et al. Material Reports,2019,33(5),1475. 28 Mahajan S, Patharkar A, Kuche K, et al. International Journal of Pharmaceutics,2018,548(1),540. 29 Yoo S, Hou J, Yi W, et al.Scientific Reports,2017,7(1),1071. 30 Li Y and Cao J.Science China. Life Sciences,2018,61(11),1333. 31 Mohajeri M, Behnam B and Sahebkar A.Journal of Cellular Physiology,2018,234(1),298. 32 Lin M S, Chen R T, Yu N Y, et al.Colloids and Surfaces B: Biointerfa-ces,2017,159,613. 33 Mauro N, Scialabba C, Agnello S, et al.Materials Science & Engineering: C, Materials for Biological Applications,2020,9(107),110201. 34 Tu Z, Wycisk V, Cheng C, et al.Nanoscale,2017,9(47) ,18931. 35 Lei W, Liu G, Zhang J, et al.Chemical Society Reviews,2017,46(12),3492. 36 Qin L, Jiang S, He H, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society,2020,13(318),50. 37 Cheng C A, Deng T, Lin F C, et al.Theranostics,2019,9(11),3341. 38 Martinez-Carmona M, Lozano D, Colilla M, et al.Acta Biomater,2018,65,393. 39 Senapati S, Thakur R, Verma S P, et al.J Control Release,2016,53(224),186. 40 Zhang L X, Xie X X, Liu D Q, et al.Biomaterials,2018,13(174),54. 41 Mosquera J, García I and Liz-Marzán L M.Accounts of chemical Research,2018,51(9),2305. 42 Banerjee A, Qi J, Gogoi R, et al.Journal of controlled release : official Journal of the Controlled Release Society,2016,13(238),176. 43 Chen X, Tieleman D P and Liang Q.Nanoscale,2018,10(5),2481. 44 Sallem F, Boudon J, Heintz O, et al.Dalton Transactions (Cambridge, England : 2003),2017,46(44),15386. 45 Xia Q, Zhang Y, Li Z, et al.Acta pharmaceutica Sinica B,2019,9(4),675. 46 Hu C-M J, Fang R H, Wang K-C, et al.Nature,2015,526(7571),118. 47 Wu J, Chen J, Feng Y, et al. Journal of Gene Medicine,2019,21(7),e3088. 48 Mukherjee S, Liang L and Veiseh O.Pharmaceutics,2020,12(2),E147. 49 Hou C, Galvan D D, Meng G, et al.Physical Chemistry Chemical Ph-ysics,2017,19(35),24126. 50 Das P, Colombo M, Prosperi D.Colloids and Surfaces B: Biointerfaces,2019,35(174),42. 51 Ray Chowdhuri A, Bhattacharya D, Sahu S K.Dalton transactions (Cambridge, England : 2003),2016,45(7),2963. 52 Hervault A, Dunn A E, Lim M, et al.Nanoscale,2016,8(24),12152. 53 Libutti S K, Paciotti G F, Byrnes A A, et al.Clinical Cancer Research,2010,16(24),6139. 54 US National Library of Medicine. ClinicalTrials.gov.[2012.05.02]https://clinicaltrials.gov/ct2/show/NCT00436410?term. 55 Nanospectra Biosciences Company(2016).[2016-07-08].www.nanospectra.com. 56 US National Library of Medicine. ClinicalTrials.gov.[2012.05.02]https://clinicaltrials.gov/ct2/show/NCT00848024?term. 57 US National Library of Medicine. ClinicalTrials.gov.[2016.11.03]https://clinicaltrials.gov/ct2/show/NCT01679470?term. 58 Marill J, Anesary N M, Zhang P, et al.Radiat Oncol,2014,9,150,56-67. 59 US National Library of Medicine. ClinicalTrials.gov.[2018.06.04]https://clinicaltrials.gov/ct2/show/NCT02379845?term. 60 US National Library of Medicine. ClinicalTrials.gov.[2020.01.22]https://clinicaltrials.gov/ct2/show/NCT03589339?term. 61 US National Library of Medicine. ClinicalTrials.gov.[2018.06.04]https://clinicaltrials.gov/ct2/show/NCT02805894?term. 62 US National Library of Medicine. ClinicalTrials.gov.[2017.05.10]https://clinicaltrials.gov/ct2/show/NCT01433068?term. 63 US National Library of Medicine. ClinicalTrials.gov.[2020.01.03]https://clinicaltrials.gov/ct2/show/NCT02901483?term. 64 US National Library of Medicine. ClinicalTrials.gov.[2020.01.02]https://clinicaltrials.gov/ct2/show/NCT02465593?term. 65 US National Library of Medicine. ClinicalTrials.gov.[2017.02.03]https://clinicaltrials.gov/ct2/show/NCT02721056?term. 66 US National Library of Medicine. ClinicalTrials.gov.[2017.05.10]https://clinicaltrials.gov/ct2/show/NCT02033447?term. 67 Liu X, Zhang Y, Wang Y, et al.Theranostics,2020,10(8),3793. 68 Rivera Gil P, Huhn D, del Mercato L L, et al.Pharmacological Research,2010,62(2),115. 69 US National Library of Medicine.ClinicalTrials.gov.[2020.04.20https://clinicaltrials.gov/ct2/show/NCT04094077?term. 70 US National Library of Medicine.ClinicalTrials.gov.[2018.07.13https://clinicaltrials.gov/ct2/show/NCT03308604?term.